Ribosomal Protein L15 inhibitors are a class of chemical compounds that specifically target and inhibit the function of Ribosomal Protein L15 (RPL15), a key component of the large subunit of the ribosome. RPL15 is integral to the structural stability of the ribosome and plays a crucial role in the ribosomal assembly and protein synthesis process. Located near the peptidyl transferase center, RPL15 interacts with ribosomal RNA (rRNA) and other ribosomal proteins, facilitating the binding of transfer RNA (tRNA) during translation elongation. By maintaining proper alignment within the ribosomal complex, RPL15 ensures that the growing polypeptide chain is synthesized accurately. Inhibitors of RPL15 typically work by binding to specific sites on the protein, disrupting its interaction with rRNA and tRNA, which can lead to impairments in the ribosome's ability to catalyze peptide bond formation.
The inhibition of Ribosomal Protein L15 has a direct impact on the ribosome's overall functionality, as it disrupts the coordination of the translation machinery responsible for protein production. By destabilizing RPL15's role in the ribosome, these inhibitors interfere with the correct assembly of the ribosomal subunits, leading to a reduction in the accuracy or efficiency of protein synthesis. Researchers utilize RPL15 inhibitors to study the precise function of this ribosomal protein and its contributions to the broader mechanisms of translation. Through these inhibitors, scientists can explore the structural and functional relationships within the ribosome, particularly how individual proteins like RPL15 contribute to the proper folding and activity of rRNA. Additionally, these inhibitors offer insight into the evolutionary conservation of ribosomal proteins across species, revealing how variations in ribosomal components influence the translation process. By targeting RPL15, researchers can gain a deeper understanding of the molecular processes underlying ribosome assembly and translational regulation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
May bind to DNA, inhibiting RNA synthesis and potentially affecting RPL15 transcription. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Could inhibit translation, possibly affecting the synthesis of RPL15. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $52.00 $125.00 $182.00 | 11 | |
Might inhibit protein synthesis, potentially affecting RPL15 expression. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Could inhibit peptide bond formation, possibly impacting RPL15 synthesis. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Might cause premature chain termination during translation, affecting RPL15 synthesis. | ||||||
Emetine | 483-18-1 | sc-470668 sc-470668A sc-470668B sc-470668C | 1 mg 10 mg 50 mg 100 mg | $440.00 $900.00 $1400.00 $2502.00 | ||
Could inhibit protein synthesis at the elongation stage, potentially impacting RPL15 expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Might inhibit mTOR, a regulator of protein synthesis, potentially affecting RPL15 expression. | ||||||
Silvestrol | 697235-38-4 | sc-507504 | 1 mg | $920.00 | ||
Could inhibit the initiation of translation, potentially affecting RPL15 synthesis. | ||||||
Myriocin (ISP-1) | 35891-70-4 | sc-201397 | 10 mg | $150.00 | 8 | |
Might inhibit serine palmitoyltransferase, potentially affecting lipid synthesis and indirectly RPL15 expression. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
Could inhibit glycolysis, potentially affecting energy production and indirectly RPL15 expression. | ||||||